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Capsule  
 
Women with endometriosis achieving singleton pregnancies with in vitro fertilization do not 
face an increased risk of miscarriage. 
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Abstract 
 
Objective: To evaluate whether women with endometriosis achieving singleton pregnancies 
with in vitro fertilization (IVF) face an increased risk of miscarriage.  
Design: Matched case-control study 
Setting: Two Italian infertility Units. 
Patients:	Women achieving singleton pregnancies with the use of IVF were considered. Cases 
were women with a history of surgery for endometriosis and those who were documented the 
presence of ovarian endometriomas at the time of the IVF cycle (n=313). Controls were 
matched to cases by age (± 6 months), type of cycle (fresh or frozen cycle) and study period 
(n=313). 
Interventions: Retrospective review of women undergoing IVF. 
Main outcome measures: Rate of miscarriage before 12 weeks’ gestation 
Results: The number of miscarriages in women with and without endometriosis was similar, 
being 48 (15%) and 60 (19%), respectively. The Odds Ratio (OR) of miscarriage in affected 
women was 0.76 (95%CI: 0.50-1.16). The OR adjusted for body mass index, parity, duration of 
infertility and male factor was 0.81 (95%CI: 0.53-1.25). Subgroup analyses according to the 
type of cycle, the number of embryos transferred, the presence of endometriomas and the 
history of surgery for endometriosis did not document any subgroup at significant increased 
risk of miscarriage. 
Conclusions:  The risk of miscarriage is not increased in women with endometriosis achieving 
pregnancy with the use of IVF. 
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Introduction 
 
The endometrium of women with endometriosis has been extensively studied and several 
differences with the endometrium of healthy women have emerged. Differences have been 
found in stem cells content, hormone sensitivity, cellular proliferation, adhesion, invasiveness, 
angiogenesis and immune-modulation (1-3). To date, however, it is still difficult to discern 
whether these differences have pathogenic implications or, conversely, whether they are 
consequent to the presence of the disease. 
Regardless of the significance of the detected differences, the observation that the endometrium 
of women with endometriosis has peculiar characteristics inevitably raises the question of the 
possible impact on pregnancy outcome and, in particular, on the risk of miscarriage. This aspect 
has received initial attention in the eighties but studies had significant flaws and evidence was 
inconclusive (4-7). Recently, interest on this argument has re-flourished (8,9) but, to date, 
definite conclusions cannot be drawn because the designs of the available studies are generally 
weak and results inevitably exposed to confounders (Table 1) (10-16).  
In vitro fertilization (IVF) may be a good model to provide evidence on the risk of miscarriage 
in women with endometriosis because, in contrast to natural pregnancies, women are actively 
followed-up in the early stage of pregnancy. Moreover, this setting allows for the recruitment of 
unaffected controls undergoing the same ascertainments. According to two recent independent 
meta-analyses on the impact of endometriosis on IVF rate of success, the Relative Risk (RR) of 
miscarriage in affected women was 1.31 (95%CI: 1.07-1.59) (17) and 1.26 (95%CI: 0.92-1.70) 
(18), respectively. However, the use of aggregate data rather than individual patient data and 
the inclusion of studies not specifically designed to evaluate the rate of miscarriage in women 
with endometriosis impedes firm conclusions. 
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In the present study, we aimed at drawing some more robust evidence on the relation between 
endometriosis and miscarriage. Specifically, we evaluated the rate of miscarriage in a large 
sample of singleton in IVF pregnancies obtained in women with endometriosis. To limit the 
impact of confounders, controls were singleton IVF pregnancies matched for age, type of cycle 
and study period.  
 
 
Materials and methods 
 
Women undergoing IVF at the infertility unit of the Fondazione Ca’ Granda, Ospedale 
Maggiore Policlinico of Milan, Italy (between January 2008 and June 2014) and at the 
infertility unit of the San Raffaele Scientific Institute, Milan (between January 2011 and June 
2014) were retrospectively reviewed. Inclusion criteria were as follows: 1) age 18-42 years, 2) 
classical IVF or intracytoplasmatic sperm injection (ICSI) cycle (fresh or frozen), 3) clinical 
singleton pregnancy as documented by a transvaginal ultrasound performed four weeks after 
embryo transfer, 4) follow-up available up to 12 weeks’ gestation. Exclusion criteria included: 
1) abnormal uterine cavity (presence of submucosal fibroids or endometrial polyps, 2) uterine 
malformations (such as in particular uterine septum), 3) abnormal karyotype of the woman or 
her partner, 4) Antiphospholipid syndrome, 4) diabetes or overt distyroidism, 5) multiple 
pregnancies (including those with an early vanishing twin), 5) suspected but not surgically or 
sonographically documented endometriosis. Women could be included only for one cycle (the 
first cycle ending into a clinical pregnancy). Cases were women with a history of surgery for 
endometriosis and those who were documented the presence of ovarian endometriomas at the 
time of the IVF cycle. Controls were matched to cases in a 1:1 ratio by age (± 6 months), type 
of cycle (fresh or frozen cycle) and study period (the following woman fulfilling the criteria for 
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selection and matching). The study was approved by the local institutional review board. An 
informed consent was not required since this is a retrospective study. However, all women 
referring to the involved units signed an informed consent for their data to be used for scientific 
purposes and agreed to be contacted after the procedure for follow-up. Women who denied this 
consent were excluded. 
Women undergoing IVF in the two Units involved followed standardized protocols. They are 
reported in details elsewhere (19,20). Of interest here is that no adjuvant treatments 
(acetylsalicylic acid, cortisone or low weight molecular heparin) were given with the exception 
of folic acid that was conversely systematically prescribed. Pre-implantation genetic screening 
(PGS) was never performed. Vaginal luteal phase support modalities varied during the 
recruitment period and between Centers but was systematically given in fresh cycles until at 
least human Chorionic Gonadotropin (hCG) identification in the maternal serum. Women 
receiving hormone replacement therapy (HRT) for frozen cycles continued the therapy for the 
whole first trimester of pregnancy (treatment was discontinued only in case of miscarriage). 
Women undergoing frozen embryo transfer replacement on a natural cycle did not receive any 
luteal phase support. Pregnancy assessment was performed testing serum hCG at +14 days after 
oocytes retrieval (adapted for frozen cycle). Women found to be pregnant were scheduled a 
second serum assessment 48 hours later and, if appropriate, they underwent transvaginal 
sonography two weeks later (thus four weeks after embryo transfer). The ultrasound scan could 
be done earlier in case of abnormalities in serum hCG growth or in the presence of suspicious 
symptoms (pain or blood loss). According to the Italian legislation, all IVF pregnancies were 
subsequently actively followed-up by repeated phone calls and, if required, by clinical and 
sonographic assessments. Miscarriage was defined as the interruption of pregnancy within 12 
weeks’ gestation (based on the crump-row length). Data was obtained from outpatient and 
inpatients charts. Discrepancies or missing data were solved by directly contacting the women. 
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The diagnosis of endometrioma was performed by transvaginal ultrasound and had to be 
documented on at least two occasions and at least two menstrual cycles apart. More 
specifically, ovarian endometrioma was defined as a round shaped cystic mass with a minimum 
diameter of 10 mm, with thick walls, regular margins, homogeneous low echogenic fluid 
content with scattered internal echoes and without papillary vascularized proliferations (21). 
Data was analyzed using the SPSS software 18.0 (Chicago, IL). Fisher Exact test, Student t-test 
and Wilcoxon non parametric test were used as appropriate. P values below 0.05 were 
considered statistically significant. Association between endometriosis and miscarriage was 
provided using Odds Ratios (OR) and relative 95%Confidence Interval (95%CI). A logistic 
regression model including baseline characteristics found to differ and univariate analyses 
(p<0.10) was used to calculate the adjusted ORs. The sample size was calculated setting type I 
and II errors at 0.05 and 0.20, respectively, expecting a miscarriage rate among controls of 20% 
and claiming as clinically relevant a relative increase of the risk of 50% (from 20% to 30%). On 
these bases, the number of women to be recruited was 300 per group. Based on the 
characteristics of the Units involved, we estimated that data from a 6-year period was 
necessary.  
 
 
Results 
 
Three hundred thirteen women with endometriosis and 313 controls without the disease were 
selected. Main baseline characteristics of the two study groups are shown in Table 2. As 
expected, indications to the procedure differed. Moreover, a statistically significant difference 
was found for the body mass index (BMI) and for the duration of infertility. Specific 
characteristics of women with endometriosis are shown in Supplementary Table 1. Two 
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hundred thirty-five cases and 235 controls (75% of the studied women) achieved pregnancy 
during a fresh cycle. Characteristics of these cycles are illustrated in Supplementary Table 2. 
Women with endometriosis required a higher dose of gonadotropins and retrieved less oocytes. 
Supplementary Table 3 illustrates the characteristics of the frozen cycles (78 per group). A 
higher proportion of control women underwent ICSI. 
Overall, the number of pregnancies ending into miscarriage in women with and without 
endometriosis was 48 (15%) and 60 (19%), respectively (p=0.25). The OR of miscarriage in 
affected women was 0.76 (95%CI: 0.50-1.16). The OR adjusted for BMI, parity, duration of 
infertility and male factor was 0.81 (95%CI: 0.53-1.25). We did subgroup analyses according to 
the type of cycle (fresh and frozen), the number of embryos transferred, the presence of 
endometriomas and the history of surgery for endometriosis (Table 3). None of these analyses 
documented any subgroup at significant increase risk of miscarriage. Further, the exclusion of 
women with adenomyosis (n=29) did not modify the general results. The adjusted OR for 
miscarriage in affected women was 0.86 (95%CI: 0.55-1.36). Finally, data was analyzed 
separately for the two involved Institutions but no main differences emerged (data not shown)  
 
 
Discussion 
 
Women with endometriosis do not appear to face an increased risk of miscarriage. Our results 
did not show an association between endometriosis and spontaneous abortion in women 
achieving singleton pregnancies with the use of IVF. Subgroup analyses indirectly confirmed 
our findings since we failed to observe any condition at increased risk. 
Albeit our results are based on a large sample size and appear robust in sensitivity analyses, 
inference of data obtained in IVF pregnancies to natural pregnancies should be made with 
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caution for at least two reasons. Firstly, natural and IVF-mediated conceptions differ in some 
aspects. In particular, natural conception occurs in the distal part of the tube, in a milieu that 
may actually be adversely affected by the peritoneal inflammation milieu (22). Moreover, the 
oocyte that is picked-up by the tubes has already been in direct contact with the inflammatory 
peritoneal fluid prior to be fertilized (23). More in general, even if the detrimental effects of 
inflammation on folliculogenesis are expected to be similar for both IVF and natural 
pregnancies, IVF has the advantage to prevent the direct contact of the oocyte with the 
peritoneal fluid. It may be speculated that the harmful milieu consequent to the presence of the 
disease may in some cases cause sublethal harm to the oocyte or to the early embryo, allowing 
conception and early embryo development but impeding progress of pregnancy over the first 
trimester of pregnancy. If this pathogenic possibility plays a role, the risk of abortion would be 
more relevant for natural pregnancy. Secondly, we cannot exclude that the hyper-stimulation 
may obscure the detrimental effects of endometriosis on the endometrium. Endometrium is 
markedly influenced by the hyper-stimulation (24) and one may speculate that, in these 
circumstances, potential differences between women with and without the disease may become 
unremarkable. Moreover, endometrial alterations encountered in endometriosis may be 
normalized by surgery. However, these two possibilities are not supported by our subgroup 
analyses. Indeed, we failed to document a statistically significant impairment on the chances of 
pregnancy when focusing on frozen cycles. Moreover, when restricting the analysis to women 
with ovarian endometriomas, we also failed to detect reduced chances of pregnancy when 
focusing on all cycles or only on fresh cycles. The statistical power of these three subgroup 
analyses was however modest (30%, 57% and 46%, respectively).  
Our observation may be at prima face surprising since it contrasts with the common view that 
endometriosis may enhance the risk of abortion (25) and with some available epidemiological 
and biological evidence. In the recent literature, we indeed identified seven studies reporting on 
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the risk of abortion in women with endometriosis (10-16), of whom three showed a statistically 
significant positive association (11,14,16) (Table 1). Moreover, two recent meta-analyses 
investigating the rate of miscarriage in women with endometriosis achieving pregnancy through 
IVF reported an about 30% increased risk (17,18). On the other hand, it is crucial to emphasize 
that the study designs of these epidemiological studies are generally weak and the results 
inevitably exposed to significant biases. The most important limitations include the lack of an 
appropriate control group, inaccuracies in the diagnosis of abortion and the confounding effect 
of age. This latter point is of utmost relevance. Multivariate analysis to adjust for age may not 
completely overcome this confounder because the relationship between age and risk of abortion 
is not linear (26). For this reason, matching rather than adjusting for age is in our opinion more 
appropriate. Noteworthy, the above-mentioned meta-analyses on the risk of abortion in women 
with endometriosis undergoing IVF do not adjust for age since the authors aggregated crude 
data (17,18). 
In our opinion, the observation that endometriosis is not associated to an increased risk of 
abortion in an IVF context does not radically contrast with the available biological evidence of 
the disease. There is undoubtedly several experimental data suggesting that the endometrium 
and the uterus of women with endometriosis may be altered and thus more prone to cause 
abortion (3). They include: 1) the endometrial resistance to selective actions of progesterone 
that affects the downstream progesterone target genes and thus, ultimately, decidualization (27), 
2) the inflammatory process whose consequences can be manifested also at endometrial level 
with in particular an increased release of reactive oxygen species (2), 3) the inadequate uterine 
contractility (28), 4) the well-known association with adenomyosis (29,30) that was suggested 
to increase the risk of abortion on its own (31). On the other hand, it is intriguing to note that 
several characteristics of the endometrium that are deemed essential to allow the implantation 
of the embryo are also concomitantly involved in the pathogenesis of endometriosis. For 
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instance, proliferation, immune-modulation, angiogenesis, adhesion are all involved in both the 
endometrial capacity to receive the embryo and the development of the disease (32-34). In other 
words, endometriosis may develop only if the endometrium is particularly healthy and 
receptive, if not even more receptive than normal. Noteworthy, a recent study investigating the 
molecular pattern involved in embryo implantation failed to document any difference between 
women with and without endometriosis (35). The endometrium of affected women might be 
paradoxically more adapted to receive the embryo and the local modifications consequent to the 
presence of the disease may only marginally affect this situation (resulting in a global absence 
of effect). This possibility is however difficult to demonstrate and remains speculative. More 
evidence is warranted.  
Some limitations of our study should be acknowledged. Firstly, we exclusively included 
women with a sonographic demonstration of a gestational sac. Since sonography was routinely 
scheduled four weeks after embryo transfer, we may have missed some very early abortions. 
The active follow-up that is routinely performed in our Units (allowing us to include also some 
very early abortions provided that a gestational sac was documented) may not fully protect our 
results from this inaccuracy. One may even claim that studying biochemical rather than 
sonographic pregnancies would have been more informative. However, we decided to exclude 
biochemical pregnancies because these pregnancies have to be considered of unknown location 
and tubal abortions cannot be excluded. Secondly, basal characteristics of the two groups differ. 
Even if we matched for the most important variables, i.e. age, type of cycle and study period, 
some differences emerged. In particular, the total dose of gonadotropins given and the number 
of oocytes retrieved differed in fresh cycles. Again, we do not estimate this limitation of main 
relevance considering that estrogens did not differ: the reduced number of oocytes retrieved 
may presumably be secondary to the well-known technical difficulties during oocytes retrieval 
in women with endometriosis (36) and, to a less extent, a lower responsiveness. Noteworthy, 
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considering the reported negative association between the number of oocytes retrieved and 
miscarriage rate following IVF treatment (37), this bias could be expected to overestimate the 
difference rather than diluting it. Finally, regardless of the direction of the interferences, we 
adjusted for all the variables who were found to differ for a p value < 0.10 (total dose of FSH 
administered and number of oocytes retrieved, BMI, previous deliveries and duration of 
infertility) Thirdly, we included among cases also women without a surgical diagnosis of 
endometriosis. In this regard, it has to be emphasized that the sonographic diagnosis of ovarian 
endometrioma is very reliable (38) and that we excluded women with a suspected diagnosis of 
endometriosis from both cases and controls. Moreover, when excluding women without a 
surgical diagnosis in the subgroup analysis, the figure did not change. Further, we could not 
evaluate the impact of the presence of deep endometriosis or adenomyosis. Their sonographic 
diagnosis is more challenging and has improved only in recent years (39). Albeit sometimes 
recorded, we deem the collection of these variables insufficiently reliable for robust analyses. 
We only performed a secondary analysis excluding women with adenomyosis because of the 
recent (and debated) view that this condition may increase per sè the risk of abortion (31). 
Fourthly, we cannot exclude that some women with endometriosis were erroneously classified 
in the control group. This is a common limitation of case-control studies on the disease and it is 
due to the lack of non-invasive tools for the diagnosis of early cases. However, the impact of 
this limitation is presumably modest considering that misclassification could occur in less than 
10% of cases and that that only mild forms of the disease can be missed (39,40). Finally, the 
karyotypes of the aborted fetuses were not available. This information would have been 
interesting since the potential detrimental effects of endometriosis are expected to exclusively 
occur in pregnancies with normal karyotypes.   
14	
	
In conclusion, endometriosis does not expose women to an increased risk of miscarriage in IVF 
cycles. Inference of this conclusion to women with endometriosis who conceive naturally is 
plausible but requires confirmation with properly designed epidemiological studies. 
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